Hamaguchi et al. [46] showed that oral administration of RA prevented the development of Aβ neuropathology in AD Tg2576 mice which express human AβPP modified by the Swedish mutation (K670N/M671L) associated with increased production of Aβ [47]. The gene discussed is APP; the disease is Alzheimer disease.